Your trusted source for investing success

Tag: drugs

Valens GroWorks Appoints President

Valens GroWorks Appoints President

Valens GroWorks (CSE:VGW)(CSE:VGW.CN) (the “Company” or “Valens“)  is pleased to announce that Mr. Saul Katz has joined the Company as its President.

Mr. Katz brings to Valens 35 years of entrepreneurship, senior management experience and scientific expertise in functional food product development and commercialization. Over his career he established research collaborations with leading

National Research Council and Lexaria Bioscience Commence Laboratory Work

National Research Council and Lexaria Bioscience Commence Laboratory Work

Lexaria Bioscience Corporation (CSE:LXX,OTCQB:LXRP) announces the start of laboratory work under its collaborative research program with the National Research Council of Canada (“NRC”), following the completion of preparation initiatives announced on March 14, 2017.

As earlier reported, several studies will be initiated in the coming months designed to optimize Lexaria’s patented technology

Isodiol International Inc. signs definitive licensing agreement with Canopy Growth Corporation for Canadian and international distribution

Isodiol International Inc. signs definitive licensing agreement with Canopy Growth Corporation for Canadian and international distribution

Isodiol International Inc. (CSE: ISOL) (OTC: LAGBF) (Frankfurt: LB6A.F) (the “Company” or “Isodiol”) a global cannabis innovator specializing in the development of pharmaceutical and consumer products is pleased to announce it has signed a licensing agreement with Canopy Growth Corporation (“Canopy”) (TSX:WEED).  

Canopy Growth is the world’s premier cannabis company that

Lexaria Bioscience Awarded Australian Patent For Cannabinoid Infused Edibles

Lexaria Bioscience Awarded Australian Patent For Cannabinoid Infused Edibles

Lexaria Bioscience Corporation (CSE:LXX,OTCQB:LXRP) is pleased to announce that the Australian Patent Office has granted patent #2015274698 which protects Lexaria’s method of improving absorption, speed of onset, and taste of cannabinoid active agents in edible products. The term of the patent is 20 years from June 10, 2015.

The issuance of this

Canadian Marijuana Stocks

Canadian Marijuana Stocks

The Canadian marijuana sector is one of the hottest growing sectors. Here’s a look at Canadian cannabis companies for investors to consider.

Isodiol International Inc. Announces Corporate Update

Isodiol International Inc. Announces Corporate Update

Isodiol International Inc. (CSE:ISOL) (OTC: LAGBF) (FSE: LB6A.F) a global cannabis innovator specializing in the development of pharmaceutical and consumer products, today released its unaudited consolidated sales figures for the month of June 2017. The company recorded sales of $1,843,173 CAD for the thirty-day period ended June 30, 2017.  Total

The Green Organic Dutchman Holdings Ltd. Hires New President & Strategic Advisor

The Green Organic Dutchman Holdings Ltd. Hires New President & Strategic Advisor

The Green Organic Dutchman Holdings Ltd. (the “Company”) is pleased to announce, following an extensive search, the appointment of Csaba Reider as the Company’s new President and Marc Bertrand as the Company’s new Strategic Advisor.
Csaba Reider

Mr. Reider is a high-energy senior executive with multinational experience in growing companies through demonstrated

Q BioMed Inc : SeeThruEquity Issues Update on Q BioMed Inc. (QBIO)

Q BioMed Inc : SeeThruEquity Issues Update on Q BioMed Inc. (QBIO)

SeeThruEquity, a leading independent equity research and corporate access firm focused on small-cap and micro-cap public companies, today announced it has issued an update on Q BioMed Inc. (OTCQB:QBIO).

Q BioMed Inc. (OTCQB: QBIO) is a biomedical acceleration and development company focused on identifying, acquiring and licensing attractive biomedical assets from small

Enter Your Log In Credentials
×

Privacy & Legal Policy

Privacy Policy

×
Investing News Network